Your browser doesn't support javascript.
loading
Traditional Chinese medicine for transformation of gastric precancerous lesions to gastric cancer: A critical review.
Zhong, Yi-Lin; Wang, Peng-Qian; Hao, Dan-Li; Sui, Feng; Zhang, Feng-Bin; Li, Bing.
  • Zhong YL; Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.
  • Wang PQ; Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.
  • Hao DL; Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.
  • Sui F; Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.
  • Zhang FB; Department of Gastroenterology, The Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, Hebei Province, China.
  • Li B; Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China. libingtcm@163.com.
World J Gastrointest Oncol ; 15(1): 36-54, 2023 Jan 15.
Article en En | MEDLINE | ID: mdl-36684050
Gastric cancer (GC) is a common gastrointestinal tumor. Gastric precancerous lesions (GPL) are the last pathological stage before normal gastric mucosa transforms into GC. However, preventing the transformation from GPL to GC remains a challenge. Traditional Chinese medicine (TCM) has been used to treat gastric disease for millennia. A series of TCM formulas and active compounds have shown therapeutic effects in both GC and GPL. This article reviews recent progress on the herbal drugs and pharmacological mechanisms of TCM in preventing the transformation from GPL to GC, especially focusing on anti-inflammatory, anti-angiogenesis, proliferation, and apoptosis. This review may provide a meaningful reference for the prevention of the transformation from GPL to GC using TCM.
Palabras clave